Disposition of 2388 shares by Colin McHugh of Accolade at 3.595 subject to Rule 16b-3
ACCD Stock | USD 3.53 0.04 1.12% |
About 66% of Accolade's investor base is looking to short. The analysis of the overall investor sentiment regarding Accolade suggests that many traders are alarmed. The current market sentiment, together with Accolade's historical and current headlines, can help investors time the market. In addition, many technical investors use Accolade stock news signals to limit their universe of possible portfolio assets.
Accolade |
Filed transaction by Accolade Officer: Chief Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at zacks.com
Accolade Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Accolade can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Accolade Fundamental Analysis
We analyze Accolade's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accolade using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accolade based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Accolade is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Accolade Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Accolade stock to make a market-neutral strategy. Peer analysis of Accolade could also be used in its relative valuation, which is a method of valuing Accolade by comparing valuation metrics with similar companies.
Peers
Accolade Related Equities
HQY | HealthEquity | 1.59 | ||||
TXG | 10X Genomics | 1.07 | ||||
TDOC | Teladoc | 0.64 | ||||
GEHC | GE HealthCare | 0.53 | ||||
PGNY | Progyny | 0.20 | ||||
GDRX | Goodrx Holdings | 0.61 | ||||
CERT | Certara | 3.37 |
Complementary Tools for Accolade Stock analysis
When running Accolade's price analysis, check to measure Accolade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accolade is operating at the current time. Most of Accolade's value examination focuses on studying past and present price action to predict the probability of Accolade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accolade's price. Additionally, you may evaluate how the addition of Accolade to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Transaction History View history of all your transactions and understand their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |